Biocatalysis is a Key Technology for Successful Chiral Synthesis at Almac
Dr Tom Moody, Head of Biocatalysis and Isotope Chemistry and Dr Stefan Mix, Biocatalysis Team Leader at Almac describe the latest biocatalytic technologies developed by the company and how they are assisting in API development.
The technology is used to support its broader chemistry offerings for the synthesis of advanced chiral intermediates and APIs for pharmaceutical and biotech customers.
